This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sieprawska-Lupa, M.
Right arrow Articles by Potempa, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sieprawska-Lupa, M.
Right arrow Articles by Potempa, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2004, p. 4673-4679, Vol. 48, No. 12
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.12.4673-4679.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Degradation of Human Antimicrobial Peptide LL-37 by Staphylococcus aureus-Derived Proteinases

Magdalena Sieprawska-Lupa,1 Piotr Mydel,1 Katarzyna Krawczyk,1 Kinga Wójcik,1 Magdalena Puklo,1 Boguslaw Lupa,1 Piotr Suder,2 Jerzy Silberring,2 Matthew Reed,3 Jan Pohl,3 William Shafer,4,5 Fionnuala McAleese,6 Timothy Foster,6 Jim Travis,7 and Jan Potempa1,7*

Department of Microbiology, Faculty of Biotechnology,1 Faculty of Chemistry and Regional Laboratory, Jagiellonian University, Kraków, Poland,2 Moyne Institute for Preventive Medicine, Trinity College, Dublin, Ireland,6 Microchemical Facility of the Winship Cancer Institute,3 Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta,4 Laboratories of Microbial Pathogenesis, Veterans Affairs Medical Center, Decatur,5 Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia7

Received 2 April 2004/ Returned for modification 26 July 2004/ Accepted 16 August 2004

Cathelicidin LL-37 is one of the few human bactericidal peptides with potent antistaphylococcal activity. In this study we examined the susceptibility of LL-37 to proteolytic degradation by two major proteinases produced by Staphylococcus aureus, a metalloproteinase (aureolysin) and a glutamylendopeptidase (V8 protease). We found that aureolysin cleaved and inactivated LL-37 in a time- and concentration-dependent manner. Analysis of the generated fragments by mass spectroscopy revealed that the initial cleavage of LL-37 by aureolysin occurred between the Arg19-Ile20, Arg23-Ile24, and Leu31-Val32 peptide bonds, instantly annihilating the antibacterial activity of LL-37. In contrast, the V8 proteinase hydrolyzed efficiently only the Glu16-Phe17 peptide bond, rendering the C-terminal fragment refractory to further degradation. This fragment (termed LL-17-37) displayed antibacterial activity against S. aureus at a molar level similar to that of the full-length LL-37 peptide, indicating that the antibacterial activity of LL-37 resides in the C-terminal region. In keeping with LL-37 degradation by aureolysin, S. aureus strains that produce significant amounts of this metalloprotease were found to be less susceptible to LL-17-37 than strains expressing no aureolysin activity. Taken together, these data suggest that aureolysin production by S. aureus contributes to the resistance of this pathogen to the innate immune system of humans mediated by LL-37.


* Corresponding author. Mailing address: Department of Biochemistry and Molecular Biology, University of Georgia, Life Science Bldg., East Green St., Athens, GA 30602. Phone: (706) 542-1713. Fax: (706) 542-3719. E-mail: potempa{at}uga.edu.


Antimicrobial Agents and Chemotherapy, December 2004, p. 4673-4679, Vol. 48, No. 12
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.12.4673-4679.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Epand, R. F., Wang, G., Berno, B., Epand, R. M. (2009). Lipid Segregation Explains Selective Toxicity of a Series of Fragments Derived from the Human Cathelicidin LL-37. Antimicrob. Agents Chemother. 53: 3705-3714 [Abstract] [Full Text]  
  • Kooi, C., Sokol, P. A. (2009). Burkholderia cenocepacia zinc metalloproteases influence resistance to antimicrobial peptides. Microbiology 155: 2818-2825 [Abstract] [Full Text]  
  • Bergsson, G., Reeves, E. P., McNally, P., Chotirmall, S. H., Greene, C. M., Greally, P., Murphy, P., O'Neill, S. J., McElvaney, N. G. (2009). LL-37 Complexation with Glycosaminoglycans in Cystic Fibrosis Lungs Inhibits Antimicrobial Activity, Which Can Be Restored by Hypertonic Saline. J. Immunol. 183: 543-551 [Abstract] [Full Text]  
  • Thwaite, J. E., Humphrey, S., Fox, M. A., Savage, V. L., Laws, T. R., Ulaeto, D. O., Titball, R. W., Atkins, H. S. (2009). The cationic peptide magainin II is antimicrobial for Burkholderia cepacia-complex strains. J Med Microbiol 58: 923-929 [Abstract] [Full Text]  
  • Stromstedt, A. A., Pasupuleti, M., Schmidtchen, A., Malmsten, M. (2009). Evaluation of Strategies for Improving Proteolytic Resistance of Antimicrobial Peptides by Using Variants of EFK17, an Internal Segment of LL-37. Antimicrob. Agents Chemother. 53: 593-602 [Abstract] [Full Text]  
  • Salinger, N., Kokona, B., Fairman, R., Okeke, I. N. (2009). The Plasmid-Encoded Regulator Activates Factors Conferring Lysozyme Resistance on Enteropathogenic Escherichia coli Strains. Appl. Environ. Microbiol. 75: 275-280 [Abstract] [Full Text]  
  • Overhage, J., Campisano, A., Bains, M., Torfs, E. C. W., Rehm, B. H. A., Hancock, R. E. W. (2008). Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation. Infect. Immun. 76: 4176-4182 [Abstract] [Full Text]  
  • Karlsson, C., Andersson, M.-L., Collin, M., Schmidtchen, A., Bjorck, L., Frick, I.-M. (2007). SufA a novel subtilisin-like serine proteinase of Finegoldia magna. Microbiology 153: 4208-4218 [Abstract] [Full Text]  
  • Brissette, C. A., Lukehart, S. A. (2007). Mechanisms of Decreased Susceptibility to {beta}-Defensins by Treponema denticola. Infect. Immun. 75: 2307-2315 [Abstract] [Full Text]  
  • Prat, C., Bestebroer, J., de Haas, C. J. C., van Strijp, J. A. G., van Kessel, K. P. M. (2006). A New Staphylococcal Anti-Inflammatory Protein That Antagonizes the Formyl Peptide Receptor-Like 1. J. Immunol. 177: 8017-8026 [Abstract] [Full Text]  
  • Sigurdardottir, T., Andersson, P., Davoudi, M., Malmsten, M., Schmidtchen, A., Bodelsson, M. (2006). In Silico Identification and Biological Evaluation of Antimicrobial Peptides Based on Human Cathelicidin LL-37.. Antimicrob. Agents Chemother. 50: 2983-2989 [Abstract] [Full Text]  
  • Thwaite, J. E., Hibbs, S., Titball, R. W., Atkins, T. P. (2006). Proteolytic Degradation of Human Antimicrobial Peptide LL-37 by Bacillus anthracis May Contribute to Virulence.. Antimicrob. Agents Chemother. 50: 2316-2322 [Abstract] [Full Text]  
  • Takeuchi, F., Watanabe, S., Baba, T., Yuzawa, H., Ito, T., Morimoto, Y., Kuroda, M., Cui, L., Takahashi, M., Ankai, A., Baba, S.-i., Fukui, S., Lee, J. C., Hiramatsu, K. (2005). Whole-Genome Sequencing of Staphylococcus haemolyticus Uncovers the Extreme Plasticity of Its Genome and the Evolution of Human-Colonizing Staphylococcal Species. J. Bacteriol. 187: 7292-7308 [Abstract] [Full Text]  
  • Nordahl, E. A., Rydengard, V., Morgelin, M., Schmidtchen, A. (2005). Domain 5 of High Molecular Weight Kininogen Is Antibacterial. J. Biol. Chem. 280: 34832-34839 [Abstract] [Full Text]  
  • Fehri, L. F., Sirand-Pugnet, P., Gourgues, G., Jan, G., Wroblewski, H., Blanchard, A. (2005). Resistance to Antimicrobial Peptides and Stress Response in Mycoplasma pulmonis. Antimicrob. Agents Chemother. 49: 4154-4165 [Abstract] [Full Text]  
  • Tzeng, Y.-L., Ambrose, K. D., Zughaier, S., Zhou, X., Miller, Y. K., Shafer, W. M., Stephens, D. S. (2005). Cationic Antimicrobial Peptide Resistance in Neisseria meningitidis. J. Bacteriol. 187: 5387-5396 [Abstract] [Full Text]